InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,304.80
(
0.47%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.62
(
0.23%
)
Bitcoin
61,838.73
(
0.35%
)
Post# of 252412
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

nsomniyak

Send PM Follow Ignore
Followers 293
Posts 21239
Boards Moderated 18
Alias Born 07/25/2003

nsomniyak

Member Level

Re: DewDiligence post# 243906

Thursday, 09/22/2022 10:29:11 AM

Thursday, September 22, 2022 10:29:11 AM

Post# of 252412
I dug around after my post to you and I found this post on this board (dated 7/18/22)

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169432301&txt2find=sesn

The author states that the Roche payment would be (up to?) $30M, or about .15 per share, if Roche initiates a Phase 3 trial on EBI-031 by the end of 2026. Assuming the share structure has not changed since then (?) that would imply a CVR value of up to .15, would which then need to be discounted in two ways - the payment is not certain and might not occur until 27 months from now.

I have not personally validated those numbers.

If I could afford to buy all of them, I would not need to buy any of them and I sure wouldn't be spending time on the message boards!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up